Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag and Cyclosporine in Pediatric Severe Aplastic Anemia
NCT03243656Phase 4Completed
- Sponsor
- Assiut University
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eltrombopag in aplastic anemia (2 arms), sponsored by Assiut University. Primary endpoints: Changes in Platelet count at 52 Weeks, Changes in hemoglobin count at 52 Weeks and 3 more. Started Dec 2017; status: completed.
02
Drugs
eltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT03243656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03243656.